[ET Net News Agency, 22 November 2022] ALI HEALTH (00241) fell 2.84% to HK$5.47.
It hits an intra-day low of HK$5.46, and an intra-day high of HK$5.83. The total shares
traded was 63.38 million, with a value of HK$357.18m. The active buy/sell ratio is 54:46,
with net buying turnover of HK$31.25m. MORGAN STANLEY HK SEC accounts for greatest net
responsive buying turnover of HK$12.75m, with volume weighted average price of HK$5.607.
BARCLAYS CAPITAL ASIA accounts for greatest net responsive selling turnover of HK$12.96m,
with volume weighted average price of HK$5.646. The stock has fallen a combined 6.97% over
the past 2 consecutive trading days.
The Hang Seng Index now fell 339 points, or 1.92% to 17,316; the Hang Seng China
Enterprises Index now fell 136 points, or 2.28% to 5,864; the Hang Seng TECH Index now
fell 138 points, or 3.81% to 3,493; with an overall turnover of HK$97.6b.
The SSE Composite Index now fell 3 points, or 0.11% to 3,081, with an overall turnover
of RMB352.85b.
The SZSE Component Index now fell 164 points, or 1.48% to 10,970, with an overall
turnover of RMB180.06b.
Basic Information
=================
----------------------------------
Nominal 5.470 % Chg -2.84%
High 5.830 Low 5.460
Shares Tr 63.38m Turnover 357.18m
10-D SMA 5.152 %H.V 97.865
20-D SMA 4.457 VWAP 5.636
50-D SMA 4.002 RSI14 65.367
----------------------------------
Status: Active buy/sell ratio is 54:46, with net buying turnover of HK$31.25m, falling a
combined 6.97% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
ALI HEALTH (00241) 5.47 -2.84
SINO BIOPHARM (01177) 4.21 -4.10
INNOVENT BIO (01801) 29.20 -6.86
PA GOODDOCTOR (01833) 17.66 -7.73
JXR (01951) 4.93 -6.98
FOSUN PHARMA (02196) 24.75 -5.71
WUXI BIO (02269) 48.50 -4.53
CANSINOBIO (06185) 108.70 -7.88
JD HEALTH (06618) 61.80 -3.59
AKESO-B (09926) 32.95 -5.99
---------------------------------------------
(ed)